The preceding paper (1) describes the isolation and some of the physical chemical characteristics of a fraction of human plasma which precipitates at low temperatures in the presence of heparin. Evidence was presented suggesting that the fraction is closely related to or associated with fibrinogen. This paper is concerned with an account of the method routinely employed for estimating the fraction, and with a presentation of data obtained by this method in normal individuals of all ages, and serially in ill patients. Attempts have been made to correlate the changes in the component with other recognized measurements of inflammatory disease.
The preceding paper (1) describes the isolation and some of the physical chemical characteristics of a fraction of human plasma which precipitates at low temperatures in the presence of heparin. Evidence was presented suggesting that the fraction is closely related to or associated with fibrinogen. This paper is concerned with an account of the method routinely employed for estimating the fraction, and with a presentation of data obtained by this method in normal individuals of all ages, and serially in ill patients. Attempts have been made to correlate the changes in the component with other recognized measurements of inflammatory disease.
MATERIALS AND METHODS
Method of estimating the heparin-precipitable component. In earlier studies (2) of the heparin-precipitable fraction (HPF), observations were recorded by gross estimation of the amount and density of precipitates appearing in appropriately heparinized plasma after it had remained at 20 C for approximately 18 hours. Based upon preliminary experiments, an empirical method of measuring the precipitate was developed early in this investigation. Subsequent studies, presented in detail in the preceding paper, have suggested a number of possible improvements in this technique. However, in order that uniform observations could be made, the procedure described in detail below was adopted and employed unchanged throughout the investigation.
Five ml. of venous blood was taken from the fasting patient into a sterile rubber-stoppered glass tube con-1-Aided in part by grants from the American Heart Association, the Minnesota Heart Association, and 8 (0.1 ml. commercial heparin containing 10 mg. per ml. or 100 units per ml. of sodium heparin) and mixed gently by inversion. After centrifugation at room temperature (2,500 rpm for 15 to 20 minutes) 2.0 ml. of supernatant plasma was pipetted into a sterile, acid-cleaned glass tube (14 X 100 mm.), covered, and the tube placed in a cold room maintained at 20 C. The pH at room temperature of plasmas after these manipulations was usually between 7.8 and 7.9. All subsequent operations during centrifugation and washing of the precipitates were carried out at 2°C. After standing 16 to 18 hours at this temperature, the tubes were centrifuged at 2,200 rpm for 10 minutes in an International refrigerated centrifuge at 20 C, the supernatant plasma poured off, and 3.0 mL cold 0.05 M, pH 7.4 phosphate buffer was added. The precipitate was mixed by thumping the tube repeatedly with the index finger. After recentrifugation the supernate was decanted and the tube inverted to drain for 5 minutes; the precipitate was then rewashed with an additional 3.0 ml. of cold buffer. After this second wash, 1.5 ml. of the buffer was added to the tube, and the tube placed in a water bath at 370 C for 30 minutes. The precipitates rapidly went back into solution. One and five-tenths ml. of biuret reagent (3) was added to the redissolved precipitate, and after 30 minutes the optical density read against an identically run buffer blank at 555 m#& in a Coleman Jr. spectrophotometer. The protein content of the precipitate from 2.0 mL of plasma was calculated from the optical density by reference to standard curves and expressed as grams per 100 ml. plasma. The standard was a solution of crystalline bovine serum albumin, the protein content of which was determined by the micro-Kjeldahl method (4) . Results of replicate determinations on pooled plasma samples agreed within + 0.02 gm. per cent by the method.
Fibrinogen determination. Plasma fibrinogen was estimated by a modification of the methods of Saifer and Newhouse (5) and Morrison (6) using oxalated plasma.
Two ml. of plasma was placed in a Petri dish containing 5.0 ml. of pH 6.3 phosphate-saline buffer solution.
Four-tenths ml. of a freshly prepared thrombin solution in 0.9 per cent NaCi (8 mg. Parke-Davis Thrombin, Topical per ml. saline) was then added with gentle swirling to complete mixing. The clot which had formed after standing one hour at room temperature was washed twice with 0.9 per cent NaCl and twice with distilled water. After washing, the clot was collected, dried at 900 C for 18 hours, and weighed. A factor of 0.83 was applied to correct for occlusion of other plasma proteins, as suggested by Saifer and Newhouse (5) , and the final result expressed as grams per 100 ml. plasma. Replicate determinations by this method agreed within ± 0.02 gm.
per cent.
Erythrocyte sedimentation rate (ESR). The method of Westergren was employed throughout, using dry "double-oxalate" as the anticoagulant. The values given represent the fall in mm. in one hour at room temperature.
C-reactive protein (CRP). CRP was determined on serum specimens by the method described by Anderson and McCarty (7) The clinical findings are presented schematically at the top of the chart, the C-reactive protein in the center, and the HPF (solid line), fibrinogenl (dotted line) and ESR (dot-dash line) are given below. HPF reached 1.38 gin. per cent initially and fell abruptly to low levels with ACTH treatment Fibrinogen and ESR, although elevated initially, fell more gradually to normal levrels. Note that a high initial HPF/fibrinogen ratio decreased abruptly during recovery to the low values characteristic of normal individuas. 607 apparent difference in the mean values of children and adults, however, may be due to differences other than those determined by age alone, since the groups were composed of individuals of entirely different economic, social, and nutritional status.
Since it was evident early in this investigation that HPF resembled fibrinogen in certain respects, this protein was assayed simultaneously with HPF. The mean value for fibrinogen in 506 healthy individuals, given in section B of Table I , was approximately 0.22 gm. per cent, the oldest group of males having slightly higher values than the other groups. This mean fibrinogen value is somewhat lower than some normal data (9), but comparable to those of Saifer and Newhouse (5) . Since the data (see below) on ill patients appeared to lend significance to changes in the ratio HPF/fibrinogen, this value was calculated for each pair of determinations in the healthy groups; the average ratios derived in this manner were 0.458 (range 0.21 to 0.78) for the youngest group, 0.709 (range 0.33 to 1.23) for the middle group, and 0.568 (range 0.27 to 1.17) for the old- in HPF which were observed for the group as a whole.
In all but eight of the rheumatic fever patients, the initial HPF values obtained were above 0.24 gm. per cent, which represents the probable upper limit of normal. The height of initial values roughly correlated with the severity of the process as gauged clinically by "toxicity," presence of pericardial friction rub, fever, joint manifestations, and by markedly increased leucocyte count and ESR.
The patient whose clinical course is shown in Figure 2 illustrates and CRP was present in the serum. Serial studies during the course of steroid-induced diureses in these patients ( Figure 6 Figure 6 ) illustrate clearly the independent variations in the levels of the various acute phase reactions and HPF.
The relation between HPF and simultaneously determined clottable protein values in the rheumatic fever patients is given by the regression diagram in Figure 7d , which was constructed from the data of 38 patients on whom simultaneous values were available. The extent and slope of the regression of normal values is significantly different from that of the rheumatic fever patients, corroborating for the group of patients the serial relationship between HPF and fibrinogen previously shown for individual patients.
DISCUSSION
The data presented in this paper allow a quantitative analysis of the occurrence of a heparin-pre- The generally higher level of HPF in adult females is not explained, although preliminary data indicating that a rise in HPF occurs before and during menstruation may account, in part, for the difference between sexes. It also seems possible that some of the high values, which are responsible for slight skewing of frequency distribution of all data, may be due to the inclusion as normal subjects of individuals having asymptomatic illness not detected by physical examination. The importance of this consideration in interpreting "normal" data describing other "acutephase" phenomena has been stressed in the literature (9, 12) .
The earliest studies of HPF in humans (2) included only patients with acute rheumatic fever, rheumatoid arthritis, and a few normal adults and infants. As the investigation was broadened it became clear that elevated HPF values were also characteristic of patients having bacterial meningitis or other pyogenic infection, acute streptococcal pharyngitis, or disseminated malignancy. Definitely elevated levels of the fraction thus appear to characterize inflammatory or necrotizing disorders in general .rather than any specific disease process. Furthermore, data correlating HPF with the clinical status of the patient indicate that the levels in the plasma are roughly proportional to the severity of the disease under study. There-fore, the clinical studies indicate that the occurrence of high levels of a cold-insoluble, heparinprecipitable component in plasma may be added to the long list of so-called "acute-phase" reactions (12) being continuously depleted as the fibrinoid deposits characteristic of these diseases are being laid down in various organs. The observation in the case of polyarteritis of a progressive decrease in HPF to low levels prior to death, with the development of widespread vascular fibrinoid lesions, would be compatible with this hypothesis. However, the occurrence of abnormally high levels of HPF in acute rheumatic fever and rheumatoid arthritis favors the interpretation that HPF simply represents another inexplicable acute phase reaction. Therefore, no interpretations concerning the role of HPF in disease mechanisms can be made at the present time. Further investigation of the problem along these lines would seem warranted.
SUMMARY AND CONCLUSION
The occurrence in health and disease and the clinical significance of a protein fraction of human plasma characterized by cold-insolubility in combination with heparin have been studied by means of an empirical technique of measurement sufficiently reliable to allow quantitative interpretation of serial changes in plasma levels. The data allow the conclusions that normal individuals have low levels of the fraction, and that these levels become greatly increased as a result of most acute inflammatory or necrotizing diseases. The appearance of the fraction in increased amounts represents another reaction in the category of "acutephase" phenomena. The data support the other items of evidence indicating that the fraction may 615
